BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25175334)

  • 1. Heparin-Binding Proteins (Chemokines and Defensins) and their complexes with glycosaminoglycans from the solution NMR perspective.
    Pomin VH
    Curr Protein Pept Sci; 2014; 15(7):738-44. PubMed ID: 25175334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current structural biology of the heparin interactome.
    Pomin VH; Mulloy B
    Curr Opin Struct Biol; 2015 Oct; 34():17-25. PubMed ID: 26038285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the interactions of vMIP-II, and a dimeric variant of vMIP-II, with glycosaminoglycans.
    Zhao B; Liwang PJ
    Biochemistry; 2010 Aug; 49(33):7012-22. PubMed ID: 20712376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution.
    Hricovíni M; Guerrini M; Bisio A; Torri G; Naggi A; Casu B
    Semin Thromb Hemost; 2002 Aug; 28(4):325-34. PubMed ID: 12244479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chapter 4. Interactions of chemokines with glycosaminoglycans.
    Hamel DJ; Sielaff I; Proudfoot AE; Handel TM
    Methods Enzymol; 2009; 461():71-102. PubMed ID: 19480915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.
    Kuschert GS; Coulin F; Power CA; Proudfoot AE; Hubbard RE; Hoogewerf AJ; Wells TN
    Biochemistry; 1999 Sep; 38(39):12959-68. PubMed ID: 10504268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural view of glycosaminoglycan-protein interactions.
    Imberty A; Lortat-Jacob H; Pérez S
    Carbohydr Res; 2007 Feb; 342(3-4):430-9. PubMed ID: 17229412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the structure and function of chemokine receptor:chemokine complexes from an experimental perspective.
    Gustavsson M
    J Leukoc Biol; 2020 Jun; 107(6):1115-1122. PubMed ID: 31965639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a glycosaminoglycan binding surface on human interleukin-8.
    Kuschert GS; Hoogewerf AJ; Proudfoot AE; Chung CW; Cooke RM; Hubbard RE; Wells TN; Sanderson PN
    Biochemistry; 1998 Aug; 37(32):11193-201. PubMed ID: 9698365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-phase binding assay to study interaction of chemokines with glycosaminoglycans.
    Kuschert GS; Hubbard RE; Power CA; Wells TN; Hoogewerf AJ
    Methods Enzymol; 1997; 287():369-78. PubMed ID: 9330333
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterizing protein-glycosaminoglycan interactions using solution NMR spectroscopy.
    Joseph PR; Poluri KM; Sepuru KM; Rajarathnam K
    Methods Mol Biol; 2015; 1229():325-33. PubMed ID: 25325963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution NMR characterization of chemokine CXCL8/IL-8 monomer and dimer binding to glycosaminoglycans: structural plasticity mediates differential binding interactions.
    Joseph PR; Mosier PD; Desai UR; Rajarathnam K
    Biochem J; 2015 Nov; 472(1):121-33. PubMed ID: 26371375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties.
    Harris N; Kogan FY; Il'kova G; Juhas S; Lahmy O; Gregor YI; Koppel J; Zhuk R; Gregor P
    Biochim Biophys Acta; 2014 Jan; 1840(1):245-54. PubMed ID: 24060749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosaminoglycans mediate cell surface oligomerization of chemokines.
    Hoogewerf AJ; Kuschert GS; Proudfoot AE; Borlat F; Clark-Lewis I; Power CA; Wells TN
    Biochemistry; 1997 Nov; 36(44):13570-8. PubMed ID: 9354625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sweet spot: how GAGs help chemokines guide migrating cells.
    Monneau Y; Arenzana-Seisdedos F; Lortat-Jacob H
    J Leukoc Biol; 2016 Jun; 99(6):935-53. PubMed ID: 26701132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saturation Transfer Difference in Characterization of Glycosaminoglycan-Protein Interactions.
    Vignovich WP; Pomin VH
    SLAS Technol; 2020 Aug; 25(4):307-319. PubMed ID: 32452261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of basic residues and quaternary structure in the function of MIP-1 beta: CCR5 binding and cell surface sugar interactions.
    Laurence JS; Blanpain C; De Leener A; Parmentier M; LiWang PJ
    Biochemistry; 2001 Apr; 40(16):4990-9. PubMed ID: 11305915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function.
    Salanga CL; Handel TM
    Exp Cell Res; 2011 Mar; 317(5):590-601. PubMed ID: 21223963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR structural studies of oligosaccharides related to cancer processes.
    Jiménez-Barbero J; Díaz MD; Nieto PM
    Anticancer Agents Med Chem; 2008 Jan; 8(1):52-63. PubMed ID: 18220505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosaminoglycans as naturally occurring combinatorial libraries: developing a mass spectrometry-based strategy for characterization of anti-thrombin interaction with low molecular weight heparin and heparin oligomers.
    Abzalimov RR; Dubin PL; Kaltashov IA
    Anal Chem; 2007 Aug; 79(16):6055-63. PubMed ID: 17658885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.